Please login to the form below

Not currently logged in
Email:
Password:

Bamboo Therapeutics

This page shows the latest Bamboo Therapeutics news and features for those working in and with pharma, biotech and healthcare.

Pfizer buys gene therapy specialist Bamboo

Pfizer buys gene therapy specialist Bamboo

Pfizer buys gene therapy specialist Bamboo. Expands pipeline with Duchenne muscular dystrophy candidate in deal worth $700m. ... Pfizer has made a play for a larger chunk of the emerging gene therapy market, agreeing a $700m deal to acquire Bamboo

Latest news

More from news
Approximately 1 fully matching, plus 0 partially matching documents found.

Latest Intelligence

  • Deal Watch August 2016 Deal Watch August 2016

    $14bn, antibiotic business interests from AstraZeneca for $1.4bn and Bamboo Therapeutics for $645m. ... 690. Bamboo Therapeutics (US). Pfizer (US). Company acquisition. Preclinical gene therapies and manufacturing plant.

More from intelligence
Approximately 0 fully matching, plus 1 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Hanson Zandi

Hanson Zandi is a Creative and Digital Healthcare Agency. We combine 30 years’ experience with the enthusiasm of a start-up...

Latest intelligence

Digital trends in B2B sales - how far behind is Pharma?
The modern approach to B2B sales is data-driven, and enabled by digital tools....
The rise of vertical integration in the US payer landscape
Is it a solution to addressing the challenges of the value-based marketplace?...
Light_bulb_Stock_Market.jpg
Creativity has lost its worth
Creativity has lost its worth, and sadly it is undermining effectiveness...

Infographics